Comparison of Appendicitis Treatments: Antibiotics vs. Appendectomy

Understanding Appendicitis

Appendicitis occurs when the appendix, a small, thin, finger-like pouch extending from the lower right side of the large intestine, becomes inflamed. This condition often arises when the appendix’s narrow opening is obstructed by feces or appendicoliths, which are deposits of feces and minerals. Common symptoms include lower right abdominal pain, loss of appetite, nausea, vomiting, bloating, inability to pass gas, and fever. If left untreated, an inflamed appendix could rupture, leading to severe abdominal infections or abscesses.

Standard Treatment Options

Traditionally, the standard treatment for appendicitis has been the surgical removal of the appendix, known as an appendectomy. Although antibiotic therapy was first proposed over six decades ago as an alternative treatment, its adoption has been limited. A 2014 report indicated that over 95% of patients with appendicitis in the United States received surgical treatment.

The CODA Trial: Study Overview

A recent large-scale trial conducted in the United States, named the Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial, aimed to compare the outcomes of antibiotic treatment versus appendectomy for appendicitis. This trial involved 25 centers across 14 states and focused on patients diagnosed with appendicitis in emergency departments who met specific selection criteria. Participants were randomly assigned to either appendectomy or a 10-day course of antibiotics, which began with 24 hours of intravenous treatment followed by oral antibiotics. The researchers assessed clinical outcomes and complications at 30 and 90 days post-treatment, including comparisons based on the presence of appendicoliths.

Trial Results

The CODA trial included a total of 1,552 adult patients. At the 30-day mark, the outcomes for those receiving antibiotic therapy were found to be non-inferior to those undergoing surgery. Notably, approximately half of the patients in the antibiotics group avoided hospitalization initially, and overall hospital stay duration was similar for both treatment groups. However, by the 90-day assessment, nearly 30% of patients in the antibiotic group had undergone an appendectomy, with 41% of those having appendicoliths and 25% of those without needing surgery. The incidence of complications was higher in the antibiotics group, with rates of 8.1 compared to 3.5 per 100 participants. Patients with appendicoliths experienced a significantly increased risk of complications (20.2 vs. 3.6 per 100 participants).

Implications of Antibiotic Therapy

Dr. David Talan, co-principal investigator from the David Geffen School of Medicine at UCLA, stated, “In terms of overall health status, antibiotics were no worse than surgery and allowed most people to avoid an operation in the short term.” However, the study also indicated that 30% of the antibiotic group required surgery within 90 days and had more follow-up hospital visits than the surgery group. Importantly, patients with appendicoliths faced a higher risk of complications and subsequent surgery. Conversely, 70% of those treated with antibiotics successfully avoided surgery, with many able to manage their treatment as outpatients, thus reducing time away from work.

Conclusion and Future Considerations

Dr. David Flum, co-lead author from the University of Washington School of Medicine, noted, “There were advantages and disadvantages to each treatment, and patients will value these differently based on their unique characteristics, concerns, and perspectives.” The findings of this study are particularly relevant in light of the ongoing COVID-19 pandemic, as they may influence how patients and healthcare providers weigh the risks and benefits of each treatment option.

References

1. The CODA Collaborative. A randomized trial comparing antibiotics with appendectomy for appendicitis. New Eng J Med 2020, Oct 5. DOI:10.1056/NEJMoa2014320.
2. University of Washington Health Sciences. Press Release 5 Oct 2020. Benefits, risks seen with antibiotics-first for appendicitis. https://www.eurekalert.org/pub_releases/2020-10/uowh-brs100120.php